Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Total 13F shares
-
64,981,734
-
Share change
-
-843,732
-
Total reported value
-
$2,817,090,446
-
Put/Call ratio
-
122%
-
Price per share
-
$43.33
-
Number of holders
-
189
-
Value change
-
-$19,419,372
-
Number of buys
-
87
-
Number of sells
-
112
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q4 2020
As of 31 Dec 2020,
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,981,734 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Bellevue Group AG, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Rock Springs Capital Management LP, Casdin Capital, LLC, and ORBIMED ADVISORS LLC.
This page lists
189
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.